AdaptHealth misses Q2 revenue and earnings estimates, shares drop 26%.

AdaptHealth Corp. reported second-quarter 2026 revenue of $740.3 million, missing analyst expectations of around $847 million by about 13%. The company posted a GAAP loss of $0.99 per share, significantly worse than the expected loss of $0.15 per share. Adjusted EBITDA was $132 million, below the anticipated $160 million. This disappointing performance led to a sharp 26% drop in the company's shares. An investigation is underway regarding potential misleading statements about the company's financial outlook, and investors who suffered losses may be eligible to participate in legal actions.